Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.408ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.408ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.408EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.408EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.408ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.408ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.256EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.256ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.256ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.256EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.256EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.256ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.256ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.7 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.7 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.7 (Alpha)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Q.7 (Alpha)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Q.7 (Alpha)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Q.7 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.7 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.7 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.460EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.460EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.144EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.144ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.144ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.144EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.144EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.144ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.144ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.288EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.288EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.288ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.288ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.288EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.288EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.288ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.288ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.249EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.249ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.249ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.249EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.249EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.249ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.378EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used